关键词: 芍药苷, 芍药苷, 芍药苷, 群体药代动力学, 群体药代动力学, 群体药代动力学, 中药, 中药, 中药, 冠心II号, 冠心II号, 冠心II号, 中药复方, 中药复方, 中药复方

Abstract:

To evaluate the effect of components in Guanxin II prescription on the pharmacokinetic profiles of paeoniflorin. Plasma concentration of Paeoniflorin in rats after intravenous injection of Paronia Pall Extract (PPE) and oral administration of PPE and three types of decoctions in Guanxin II prescription, respectively, were determined by HPLC analyses. NONMEM (nonlinear mixed-effect modeling) method was used to analyze full set of pharmacokinetic data directly. A two-compartment model with first-order degradation in absorption compartment was employed for the data analysis. The mean of population parameters, CL1, V1, CL2, V2, Ka0, and Ka1, were measured to be 0.509 L/h, 0.104 L, 0.113 L/h, 0.123 L, 0.135/h, and 0.0135/h, respectively. Inter-individual variabilities were estimated and dose formulation (DF) was identified as a significant covariate of Ka1, Ka0, and V1. It is concluded that the pharmacokinetic behaviors of paeoniflorin in rats can alter with different dose formulations.

Key words: Paeoniflorin, Paeoniflorin, Population pharmacokinetics, Population pharmacokinetics, Traditional Chinese Medicine, Traditional Chinese Medicine, Guanxin II, Guanxin II, Compound formulae, Compound formulae